Sofinnova Partners

This page shows the latest Sofinnova Partners news and features for those working in and with pharma, biotech and healthcare.

Illumina sets up first ex-US accelerator site in Cambridge

Cambridge is of course also where Illumina was carrying out the DNA sequencing for the UK’s 100, 000 Genomes Project, in collaboration with Genomics England and other partners such as ... Illumina is joining forces with several venture firms for the

Latest news

Daily Brief: Charity criticises NHSE and Vertex over Orkambi access, Sema scores again, NodThera launched

The fundraising was co-led by leading healthcare investors Sofinnova Partners and 5AM Ventures, with Epidarex Capital and F-Prime Capital Partners also taking part.
Morning brief: Allergan’s migraine results, Biktarvy approved in Europe and more

Its investors are Andera Partners (via Europe’s largest life sciences fund Biodiscovery V) and new backers, China’s Quan, plus existing investors Sofinnova Partners, IP Group, EMBL and Takeda Ventures.
News in brief, July 04, 2007

Sofinnova Partners, a French investment firm, led the Series A round, joined by additional backers Norway-based NeoMed Management and Bostonís MVM Life Science Partners. ... The lead investor was Special Situations Fund, while other investors were Fort
Boehringer Ingelheim and Ablynx sign GBP 136.5 million R&D agreement

Ablynx has raised over EUR 70 million (GBP 46.9 million) from an investor consortium which includes Abingworth Management (UK), Alta Partners (US), Biotech Fund Flanders (Belgium), Gilde Investment Management (Netherlands), ... GIMV (Belgium), KBC

More from news
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

Dr Martin Rothman joins Sofinnova Partners

Rothman brings 40 years of experience along with an international network in the medical field to Sofinnova Partners. ... Rothman said: “I am thrilled to join Sofinnova Partners’ team as venture partner.
Kala Pharma appoints Fovea founder Bernard Gilly to board

Prior to his involvement with Fovea, Dr Gilly was a venture partner with Sofinnova Partners from 2000 to 2005.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Account Executive – Account Manager – Healthcare Advertis...: £32000 - £43000 Bonus Benfits

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...: Excellent Daily Rate

Account Director - Medical Communications - London / South East: Excellent Salary and Benefits on offer

FREELANCE Account Director – Healthcare Advertising – London – 3...: Competitive Daily Rates

Account Director - Healthcare Advertising - London - 2 DAYS HOME...: £50000 - £70000

Account Director – UK Office: Excellent salary and benefits

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Account Director, Healthcare Communications: Salary TBC

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Subscribe to our email news alerts

PMHub

Add my company

W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

The relevance of patient perspectives to value: Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?: Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
The evolution of real-world studies: How industry and regulators are using real-world data...